Ebstein Anomaly — #3 Pathophysiology: Neonate with PDA

Date
October 31, 2025
URL
https://x.com/WithAScalpel/status/1984244316202545293
Categories
Ebstein Anomaly

Ebstein Anomaly — #3 Pathophysiology: Neonate with PDA

image

Core problem

Severe tricuspid regurgitation (TR) and atrialization of the right ventricle (RV) leave only a small, inefficient functional RV. Right-atrial pressure is high, so interatrial shunting is typically right-to-left (PFO/ASD) with systemic desaturation. Historical neonatal series underscore the high early risk and the utility of echocardiographic severity indices for prognostication [1]. PubMed

When a ductus is present

A patent ductus arteriosus (PDA) can create two destabilizing circuits:

  • Functional pulmonary atresia (fPA). When the RV cannot generate antegrade flow (afterload from high PVR plus severe TR), ductal flow runs from aorta to PA without forward RV ejection; cyanosis persists via right-to-left atrial shunting and the RV may become completely bypassed. Case reports describe this with color Doppler evidence of absent RV–PA forward flow [2, 3]. PubMed+1
  • Circular (recirculating) shunt with systemic steal. If pulmonary valve insufficiency is present, ductal inflow to the PA can wash retrograde across the pulmonary valve into the RV, pass through the incompetent tricuspid valve to the RA, cross the ASD, and re-enter the aorta—recirculating blood without traversing the pulmonary microcirculation. This “circular shunt” causes profound systemic runoff, hypotension, and end-organ hypoperfusion despite seemingly generous ductal flow. Early neonatal reports highlight clinical deterioration that improved after stopping prostaglandin to allow ductal closure [2, 3]. PubMed+1

Clinical expression and echocardiography

Neonates typically exhibit cyanosis, respiratory distress of variable degree, low systemic pressures, a large RA with severe TR, and hepatomegaly. Echocardiography often shows: (i) minimal/absent RV-to-PA antegrade flow; (ii) PDA left-to-right shunting; and (iii) diastolic PA-to-RV backflow when circular shunt physiology is present [2, 3]. Prognostic markers from classic series—marked cardiomegaly and high Celermajer index—correlate with early risk [1]. PubMed+2PubMed+2

Management principles

Goals: (1) deliver effective pulmonary blood flow that actually reaches the lungs, (2) protect systemic output, and (3) avoid triggers that worsen circular shunting.

1) Stabilization and physiology tuning

  • Maintain preload; avoid dehydration and excessive PEEP.
  • Use oxygen and ventilation judiciously—a rapid drop in PVR can amplify ductal runoff and circular shunt.
  • Treat tachyarrhythmias (e.g., WPW-related SVT) promptly.
  • Prostaglandin E1 (PGE): begin with the lowest effective dose; if fPA/circular shunt worsens, down-titrate or stop with close surveillance. Reports document hemodynamic improvement after PGE discontinuation when circular shunt is present [2, 3]. PubMed+1

2) Interventions to test/enable RV forward flow

  • PDA restriction or closure (catheter or surgical) can unmask/permit RV-PA antegrade flow and improve oxygenation if the RV can eject. The 2024 AATS consensus explicitly recommends attempted ductal closure (medical or interventional) in hemodynamically stable neonates at risk for or exhibiting circular shunt/fPA [4]. PubMed
  • Consider PVR reduction only after confirming that pulmonary blood actually traverses the lungs (evidence of antegrade RV-PA Doppler and no circular shunt). PubMed

3) Escalation for refractory circular shunt or RV failure

  • Emergent interruption of the circular shunt is a class recommendation in unstable neonates [4]. Options include main PA ligation/banding and PDA closure to break the loop, followed (when indicated) by systemic–PA shunt. Case literature demonstrates staged approaches—e.g., immediate PA ligation to abolish the circular shunt, then modified Starnes—with stabilization and good early outcomes [5, 6]. PubMed
  • Starnes strategy (neonatal RV exclusion with systemic-to-PA shunt). For nonfunctional RVs and persistent steal, Starnes’ neonatal RV exclusion remains a cornerstone, with contemporary use as initial palliation and a pathway either to single-ventricle circulation or (in selected centers) delayed biventricular rehabilitation [7, 4]. PubMed+1

Practical bedside cues that favor PDA restriction/closure

Worsening hypotension despite strong ductal flow, retrograde diastolic PA-to-RV color Doppler, minimal RV outflow Doppler, rising lactate with falling systemic saturations—these suggest circular shunt physiology and argue for urgent assessment to limit the ductus and restore a serial circulation [2–4]. PubMed+2PubMed+2

References

[1] Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RKH, Deanfield JE. Outcome in neonates with Ebstein’s anomaly. J Am Coll Cardiol. 1992;19(5):1041-1046. PubMed+1

[2] Paranon S, Plat-Wilson G, Marcoux M-O, Acar P. Circular shunting of blood: a complication of neonatal Ebstein anomaly. Arch Pediatr. 2010;17(12):1673-1676. PubMed

[3] Hakim K, Boussaada R, Ayari J, Imen H, Msaad H, Ouarda F, Chaker L. Circular shunt in the severe neonatal form of Ebstein’s anomaly: is prostaglandin infusion beneficial or harmful? Cardiol Tunis. 2013;9(4):73-76. PubMed

[4] Konstantinov IE, Chai P, Bacha E, Caldarone CA, da Silva JP, Da Fonseca Da Silva L, Dearani J, et al. The American Association for Thoracic Surgery (AATS) 2024 expert consensus document: Management of neonates and infants with Ebstein anomaly. J Thorac Cardiovasc Surg. 2024;168(2):311-324. PubMed

[5] Yanase Y, Watanabe M, Ishikawa N, Higami T. Surgical treatment for neonatal Ebstein’s anomaly with circular shunting. Interact Cardiovasc Thorac Surg. 2012;14(6):886-888. PubMed

[6] Hasegawa M, Iwai S, Yamauchi S, Kugo Y, Kayatani F, Takahashi K, Kawata H. Bilateral pulmonary artery banding in Ebstein’s anomaly with circular shunting. Ann Thorac Surg. 2019;107(5):e317-e319. annalsthoracicsurgery.org

[7] Starnes VA, Pitlick PT, Bernstein D, Griffin ML, Shumway NE. Ebstein’s anomaly appearing in the neonate: a new surgical approach. J Thorac Cardiovasc Surg. 1991;101(6):1082-1087. PubMed+1